Petros Pharmaceuticals, Inc. (PTPI) — Cost of Revenue
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2024 | $1.21M | -25.7% |
| 2023 | $1.63M | -28.7% |
| 2022 | $2.29M | +43.1% |
| 2021 | $1.60M | -60.5% |
| 2020 | $4.05M | — |
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2024 | $1.21M | -25.7% |
| 2023 | $1.63M | -28.7% |
| 2022 | $2.29M | +43.1% |
| 2021 | $1.60M | -60.5% |
| 2020 | $4.05M | — |